Clinical trial
Niacin Plus Statin to Prevent Vascular Events
NCT00120289 · Axio Research. LLC, Industry · Terminated
Key facts
| NCT number | NCT00120289 |
|---|---|
| Title | Niacin Plus Statin to Prevent Vascular Events |
| Official title | AIM HIGH: Niacin Plus Statin to Prevent Vascular Events |
| Lead sponsor | Axio Research. LLC, Industry |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH Abbott Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases, Heart Diseases, Cerebrovascular Accident, Coronary Disease, Atherosclerosis, Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Extended release niacin, Simvastatin |
| Enrollment | 3,414 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Jul 15, 2005 |
| Last update posted | Apr 6, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: